[ad_1]
Sun Pharma Acquisition of Two Companies: Big news related to Sun Pharma, the world’s fourth largest generic drug company, is coming out. Sun Pharma has announced to buy its significant stake in two companies in the health care sector. Know how much this deal has happened. And by when the full money will be paid.
invest in these two companies
Sun Pharma has announced in the Stock Exchange Filing that it will buy 26.09 per cent stake in Agatsa Software Pvt Ltd for Rs 30 crore in two tranches. Apart from this, the Mumbai-based health care company has bought 27.39 per cent stake in Remidio Innovative Solutions Pvt Ltd for Rs 149.9 crore. Which is an early stage digital diagnostic devices company.
Information given to the stock exchange
Sun Pharma Company has informed in the filing that its first installment will be paid as Rs 8 crore in February 2023 and Rs 22 crore in the second installment in August 2023. Apart from this, this company has bought 27.39 per cent stake in Remedio Innovative Solutions Pvt Ltd for Rs 149.9 crore. Remedio Innovative Company prepares products for the detection of eye diseases.
sun pharma results
In the quarter ended December 2022 last year of Sun Pharma, the company’s profit increased by 5.2 percent on an annual basis to Rs 2,166 crore. In the same period of the last financial year, the profit of the company stood at Rs 2,058.8 crore. In the third quarter, Sun Pharma’s income has increased by 14 percent on an annual basis to Rs 11,241 crore. In the same period of the last financial year, the company’s income was Rs 9,863 crore.
Business in more than 100 countries around the world
Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company with global revenues of over US$5.1 billion. Also providing high quality, affordable medicines to more than 100 countries around the world. Has established good trust in the health care sector across the country.
read this also-
[ad_2]
Source link